News | Image Guided Radiation Therapy (IGRT) | September 16, 2019

Artificial intelligence-powered system designed to deliver adaptive therapy treatment in a typical 15-minute timeslot

Varian Unveils Ethos Solution for Adaptive Radiation Therapy

September 16, 2019 — At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian announced Ethos therapy, an artificial intelligence (AI)-driven holistic solution designed to increase the capability, flexibility and efficiency of radiotherapy. This new solution is designed to deliver an entire adaptive treatment in a typical 15-minute timeslot, from patient setup through treatment delivery.

Adaptive therapy provides the ability to alter the treatment plan based on tumor and anatomical changes. The goal is to better target the tumor, reduce dose to healthy tissue and potentially improve overall outcomes.

The streamlined workflow of Ethos therapy is enabled by its AI-driven planning and contouring capabilities. The physician defines their clinical intent from predefined templates and the initial treatment plan is generated based on the physician's intent. The treatment plan is adapted in response to the variability of the tumor's shape and cellular characteristics, along with fluctuations in the tumor's position due to changes in nearby organs. The ability of Ethos to deliver on-couch adaptive treatment puts the patient at the center of care.

Ethos therapy offers the use of multimodality images — including magnetic resonance (MR), positron emission tomography (PET) and computed tomography (CT) — and daily iterative cone beam computed tomography (CBCT) images at the console.  By providing an up-to-date view of the patient's anatomy, Ethos therapy provides clinicians the confidence to make more informed adaptive treatment decisions. The solution is built on Varian's latest treatment delivery technology, and provides fast imaging and treatment delivery without compromising quality.

"Ethos therapy will enable our physicians to better visualize the changes in a patient's anatomy and quickly adapt the therapy accordingly to help provide better treatments to patients," said Poul Geertsen, M.D., Ph.D., head of radiotherapy, Department of Oncology at Herlev and Gentofte Hospital, Copenhagen, Denmark. "We have already delivered the first Ethos therapy treatment, and our clinical staff was impressed by the capabilities and the ability to deliver this advanced treatment in a typical timeslot."

To advance the worldwide adoption of intelligent adaptive therapy, Varian formed the Adaptive Intelligence Consortium in April 2019. Participants include clinicians and scientists from leading cancer clinics across the globe. The consortium will lead clinical trials to develop evidence-based clinical protocols for Ethos therapy.

Ethos therapy has received CE mark and is currently U.S. Food and Drug Administration (FDA) 510(k) pending and not for sale in all markets.

Watch the 2019 ASTRO VIDEO: Artificial Intelligence Driven Adaptive Radiotherapy System Begins Treating Patients — Interview with David Sjostrom, Ph.D., deputy chief physicist, Herlev Hospital

For more information: www.varian.com


Related Content

News | PET Imaging

March 23, 2023 — Nuclidium announced that the Neuroendocrine Tumors Research Foundation (NETRF) has selected the company ...

Time March 24, 2023
arrow
Feature | AIMed | By Melinda Taschetta-Millane

The 2023 AiMed Global Summit will focus on artificial intelligence (AI) in healthcare, and will offer valuable insights ...

Time March 23, 2023
arrow
News | Lung Imaging

March 22, 2023 — The Riverain Technologies ClearRead Bone Suppression solution is now available on the Siemens ...

Time March 22, 2023
arrow
News | Artificial Intelligence

March 22, 2023 — Nuance Communications, Inc., a Microsoft company, has announced DAX Express, its next milestone in its ...

Time March 22, 2023
arrow
News | Artificial Intelligence

March 17, 2023 — A new paper published in the Journal of Medical Internet Research describes how generative models such ...

Time March 17, 2023
arrow
News | Quality Assurance (QA)

March 16, 2023 — RTsafe, a leading provider of quality assurance products and services in stereotactic radiosurgery ...

Time March 16, 2023
arrow
News | Lung Imaging

March 15, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Time March 15, 2023
arrow
News | Radiation Oncology

March 14, 2023 — Elekta announced that is has signed a joint venture with China National Pharmaceutical Group Co., Ltd. ...

Time March 14, 2023
arrow
Feature | HIMSS | By Melinda Taschetta-Millane

The theme of The Healthcare Information and Management Systems Society (HIMSS23) is Health That Connects + Tech That ...

Time March 14, 2023
arrow
News | Digital Pathology

March 13, 2023 — Proscia, a leading provider of digital and computational pathology solutions, today announced that ...

Time March 13, 2023
arrow
Subscribe Now